olaparib

Olaparib is a selective and potent inhibitor of the PARP1 and PARP2 enzymes, which are involved in DNA repair.

Olaparib is approved for the treatment of BRCA-mutated advanced ovarian, breast, prostate, and pancreatic cancers.